Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Nicotine Addiction
PACTR201904758098529Phase 4Completed
- Sponsor
- Dalia Abdellateif Abdelghany
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nicotine, bupropion and Placebo-COD Research Private Ltd in nicotine dependence (4 arms), sponsored by Dalia Abdellateif Abdelghany. Primary endpoint: Smoking status at 3 months. Started Apr 2015; status: completed.
02
Drugs
nicotinebupropionPlacebo-COD Research Private Ltd
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on PACTR201904758098529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201904758098529.